Levanto Schachter

891 total citations
13 papers, 238 citations indexed

About

Levanto Schachter is a scholar working on Oncology, Electrical and Electronic Engineering and Genetics. According to data from OpenAlex, Levanto Schachter has authored 13 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Electrical and Electronic Engineering and 3 papers in Genetics. Recurrent topics in Levanto Schachter's work include CAR-T cell therapy research (6 papers), Integrated Circuits and Semiconductor Failure Analysis (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Levanto Schachter is often cited by papers focused on CAR-T cell therapy research (6 papers), Integrated Circuits and Semiconductor Failure Analysis (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Levanto Schachter collaborates with scholars based in United States and Italy. Levanto Schachter's co-authors include Abdul I. Barakat, Richard T. Maziarz, Andy Chen, Philipp W. Raess, Sarah Nagle, Eneida R. Nemecek, Brandon Hayes‐Lattin, Nausheen Ahmed, Veronika Bachanová and David L. Porter and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Biomedical Engineering.

In The Last Decade

Levanto Schachter

11 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Levanto Schachter United States	5	117	96	65	46	44	13	238
Ulrike Höller Germany	8	120 1.0×	57 0.6×	40 0.6×	59 1.3×	47 1.1×	22	279
Alexander Thiem Germany	7	120 1.0×	28 0.3×	30 0.5×	21 0.5×	37 0.8×	31	271
Maximilian Gebhard Germany	12	61 0.5×	97 1.0×	111 1.7×	7 0.2×	55 1.3×	27	379
Daljeet Chahal Canada	10	61 0.5×	91 0.9×	19 0.3×	5 0.1×	46 1.0×	38	323
G. Kessell United Kingdom	5	49 0.4×	106 1.1×	13 0.2×	12 0.3×	22 0.5×	8	265
Guangqi Qin Sweden	10	32 0.3×	172 1.8×	34 0.5×	17 0.4×	34 0.8×	17	271
Qiujin Xiao China	7	60 0.5×	124 1.3×	9 0.1×	17 0.4×	68 1.5×	14	332
Ali Bukhari United States	9	206 1.8×	14 0.1×	12 0.2×	44 1.0×	30 0.7×	25	297
Antoine Chalopin France	8	150 1.3×	146 1.5×	19 0.3×	6 0.1×	67 1.5×	14	390
Felix Neis Germany	12	37 0.3×	140 1.5×	15 0.2×	7 0.2×	30 0.7×	47	374

Countries citing papers authored by Levanto Schachter

Since Specialization

Citations

This map shows the geographic impact of Levanto Schachter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levanto Schachter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levanto Schachter more than expected).

Fields of papers citing papers by Levanto Schachter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levanto Schachter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levanto Schachter. The network helps show where Levanto Schachter may publish in the future.

Co-authorship network of co-authors of Levanto Schachter

This figure shows the co-authorship network connecting the top 25 collaborators of Levanto Schachter. A scholar is included among the top collaborators of Levanto Schachter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levanto Schachter. Levanto Schachter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Cleveland, Joseph C., et al.. (2025). A Case of HIV-Associated Primary Central Nervous System Lymphoma Refractory to Methotrexate-Based Systemic Therapy and Immune Reconstitution. Cureus. 17(3). e80273–e80273.

Wertheim, Betsy C., Douglas W. Sborov, Damian Green, et al.. (2025). Outcomes and treatment patterns in primary and secondary plasma cell leukemia: insights from a large US cohort study. Haematologica. 110(9). 2129–2138.

Pophali, Priyanka A., Joshua Fein, Kwang Woo Ahn, et al.. (2024). CD19-directed CART therapy for T-cell/histiocyte–rich large B-cell lymphoma. Blood Advances. 8(20). 5290–5296. 6 indexed citations

Williamson, Staci, Levanto Schachter, Andy Chen, et al.. (2024). Sociodemographic Factors Influencing Access to Chimeric Antigen T-Cell Receptor Therapy for Patients With Non-Hodgkin Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 25(2). e120–e125. 4 indexed citations

Ahmed, Nausheen, Muhammad Umair Mushtaq, David L. Porter, et al.. (2023). Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin Lymphoma. Transplantation and Cellular Therapy. 29(7). 449.e1–449.e7. 11 indexed citations

Wertheim, Betsy C., Denise J. Roe, Douglas W. Sborov, et al.. (2023). Plasma cell leukemia: A multicenter retrospective study of 150 patients.. Journal of Clinical Oncology. 41(16_suppl). 8014–8014. 2 indexed citations

Riedell, Peter A., Wei‐Ting Hwang, Loretta J. Nastoupil, et al.. (2022). Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell Lymphomas. Transplantation and Cellular Therapy. 28(10). 669–676. 49 indexed citations

Wertheim, Betsy C., Denise J. Roe, Douglas W. Sborov, et al.. (2022). Plasma Cell Leukemia: A Multicenter Retrospective Study of 130 Patients. Blood. 140(Supplement 1). 7144–7146. 1 indexed citations

Williamson, Staci, Rebecca Silbermann, Eva Medvedova, et al.. (2021). Second Autologous Stem Cell Transplant as Salvage in Multiple Myeloma – The Oregon Health and Science University Experience. Clinical Lymphoma Myeloma & Leukemia. 22(2). 105–112. 1 indexed citations

10.

Nagle, Sarah, Philipp W. Raess, Levanto Schachter, et al.. (2021). Prolonged hematologic toxicity following treatment with chimeric antigen receptor T cells in patients with hematologic malignancies. American Journal of Hematology. 96(4). 455–461. 44 indexed citations

11.

Gauthier, Jordan, Paula Perkins, Mazyar Shadman, et al.. (2021). CD19 CAR T-cell product type independently impacts CRS and ICANS severity in patients with aggressive NHL.. Journal of Clinical Oncology. 39(15_suppl). 7532–7532. 3 indexed citations

12.

Schachter, Levanto, et al.. (2014). Social factors, treatment, and survival in patients with advanced-stage non-small cell lung cancer. Translational Cancer Research. 3(2). 146–151. 3 indexed citations

13.

Schachter, Levanto, et al.. (2005). Computational Study of Fluid Mechanical Disturbance Induced by Endovascular Stents. Annals of Biomedical Engineering. 33(4). 444–456. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact